Microscopic disease extensions as a risk factor for loco-regional recurrence of NSCLC after SBRT

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 26-31

  Salguero, Francisco J ^a   Belderbos, Jose S A ^a   Rossi, Maddalena M G ^a   Blaauwgeers, Johannes L G ^b   Stroom, Joep ^a,c   Sonke, Jan Jakob ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c CHAMPALIMAUD FOUNDATION   (Portugal)

Author keywords

Image analysis; Lung cancer; Microscopic disease; Stereotactic body radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOSIMETRY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOW RISK POPULATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT FAILURE; TUMOR INVASION; TUMOR SCINTISCANNING;

IMAGE ANALYSIS; LUNG CANCER; MICROSCOPIC DISEASE; STEREOTACTIC BODY RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RECURRENCE; RISK FACTORS;

EID: 84888057468     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.08.028     Document Type: Article

References (38)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. R. Manser, G. Wright, and D. Hart Surgery for early stage non-small cell lung cancer Cochrane Database Syst Rev 2005 CD004699
3. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
4. A. Chi, Z. Liao, and N.P. Nguyen Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
5. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
6. N. Andratschke, F. Zimmermann, and E. Boehm Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure Radiother Oncol 101 2011 245 249
7. Y. Shimada, H. Saji, and K. Yoshida Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage Ia non-small-cell lung cancer after complete surgical resection J Thorac Oncol 7 2012 1263 1270
8. M.D. Brundage, D. Davies, and W.J. Mackillop Prognostic factors in non-small cell lung cancer: a decade of progress Chest 122 2002 1037 1057
9. Definition of volumes J ICRU 10 2010 41 53
10. P. Giraud, M. Antoine, and A. Larrouy Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning Int J Radiat Oncol Biol Phys 48 2000 1015 1024
11. I.S. Grills, D.L. Fitch, and N.S. Goldstein Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy Int J Radiat Oncol Biol Phys 69 2007 334 341
12. J. van Loon, C. Siedschlag, and J. Stroom Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features Int J Radiat Oncol Biol Phys 82 2012 448 456
13. S.H. Benedict, K.M. Yenice, and D. Followill Stereotactic body radiation therapy: the report of aapm task group 101 Med Phys 37 2010 4078 4101
14. M. Guckenberger, A. Richter, and J. Wilbert Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control Int J Radiat Oncol Biol Phys 81 2011 e275 282
15. C. Siedschlag, L. Boersma, and J. van Loon The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer Radiother Oncol 100 2011 344 350
16. J.J. Sonke, and J. Belderbos Adaptive radiotherapy for lung cancer Semin Radiat Oncol 20 2010 94 106
17. J.G. Armstrong Target volume definition for three-dimensional conformal radiation therapy of lung cancer Br J Radiol 71 1998 587 594
18. Y.E. Erdi, O. Mawlawi, and S.M. Larson Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 1997 2505 2509
19. C. Siedschlag, J. van Loon, and A. van Baardwijk Analysis of the relative deformation of lung lobes before and after surgery in patients with nsclc Phys Med Biol 54 2009 5483 5492
20. J.J. Sonke, M. Rossi, and J. Wolthaus Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam ct guidance Int J Radiat Oncol Biol Phys 74 2009 567 574
21. D. Morgensztern, S. Waqar, and J. Subramanian Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (seer) survey from 1998 to 2003 J Thorac Oncol 7 2012 1479 1484
22. D. Ball, A. Mitchell, and D. Giroux Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer: an analysis of the staging project database of the international association for the study of lung cancer J Thorac Oncol 8 2013 315 321
23. M.W. Pitz, G. Musto, and S. Navaratnam Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort Can Respir J 20 2013 30 34
24. S.H. Ou, J.A. Zell, and A. Ziogas Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California cancer registry from 1989 to 2003 Cancer 110 2007 1532 1541
25. E. Weiss, and C.F. Hess The impact of gross tumor volume (gtv) and clinical target volume (ctv) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences Strahlenther Onkol 179 2003 21 30
26. J.L. Lopez Guerra, D.R. Gomez, and S.H. Lin Risk factors for local and regional recurrence in patients with resected n0-n1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy Ann Oncol 24 2013 67 74
27. H.K. Koo, S.M. Jin, and C.H. Lee Factors associated with recurrence in patients with curatively resected stage I-II lung cancer Lung Cancer 73 2011 222 229
28. K.A. Higgins, J.P. Chino, and N. Ready Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy J Thorac Oncol 7 2012 1141 1147
29. D. Rades, C. Setter, and O. Dahl Fibroblast growth factor 2 - a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 82 2012 442 447
30. I.S. Grills, A.J. Hope, and M. Guckenberger A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393
31. G.R. Borst, J.S. Belderbos, and R. Boellaard Standardised fdg uptake: a prognostic factor for inoperable non-small cell lung cancer Eur J Cancer 41 2005 1533 1541
32. K. Clarke, M. Taremi, and M. Dahele Stereotactic body radiotherapy (sbrt) for non-small cell lung cancer (nsclc): is fdg-pet a predictor of outcome? Radiother Oncol 104 2012 62 66
33. max) on fdg-pet is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (sbrt) Radiother Oncol 101 2011 291 297
34. M.J. Burdick, K.L. Stephans, and C.A. Reddy Maximum standardized uptake value from staging fdg-pet/ct does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 78 2010 1033 1039
35. M. Agarwal, G. Brahmanday, and S.K. Bajaj Revisiting the prognostic value of preoperative (18)f-fluoro-2-deoxyglucose ((18)f-fdg) positron emission tomography (pet) in early-stage (I & II) non-small cell lung cancers (nsclc) Eur J Nucl Med Mol Imaging 37 2010 691 698
36. C.J. Hoekstra, O.S. Hoekstra, and S.G. Stroobants Methods to monitor response to chemotherapy in non-small cell lung cancer with 18f-fdg pet J Nucl Med 43 2002 1304 1309
37. M. Westerterp, J. Pruim, and W. Oyen Quantification of fdg pet studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and roi definition parameters Eur J Nucl Med Mol Imaging 34 2007 392 404
38. X. Meng, X. Sun, and D. Mu Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 82 2012 960 966